UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation

Phase 1

Terminated

Conditions: Multiple Myeloma

Interventions: Radiation: Total Skeletal Irradiation

First Posted Date: 2010-08-16

Last Posted Date: 2016-05-17

Lead Sponsor: University of Rochester

Target Recruit Count: 4

Registration Number: NCT01182233

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Fish Oil and Aspirin With Type 2 Diabetes

Phase 2

Completed

Conditions: Cardiovascular Disease

Interventions: Dietary Supplement: Fish Oil and Aspirin

First Posted Date: 2010-08-13

Last Posted Date: 2013-10-08

Lead Sponsor: University of Rochester

Target Recruit Count: 30

Registration Number: NCT01181882

Locations: 🇺🇸
Clinical Research Center of the University of Rochester Medical Center, Rochester, New York, United States

School-based Asthma Therapy: Stage 2 Effectiveness Study

Not Applicable

Completed

Conditions: Asthma

Interventions: Behavioral: School-based Care

First Posted Date: 2010-08-04

Last Posted Date: 2014-08-01

Lead Sponsor: University of Rochester

Target Recruit Count: 530

Registration Number: NCT01175369

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

School-Based Preventive Asthma Care Technology: A Trial Using a Novel Technology to Improve Adherence

Not Applicable

Completed

Conditions: Asthma

Interventions: Other: School-Based Medication Delivery

First Posted Date: 2010-08-04

Last Posted Date: 2014-02-17

Lead Sponsor: University of Rochester

Target Recruit Count: 99

Registration Number: NCT01175434

Locations: 🇺🇸
Univeristy of Rochester, Rochester, New York, United States

Phamacological Reversal of Airway Instability During Sedation

Not Applicable

Completed

Conditions: Upper Airway Obstruction

Interventions: Drug: Placebo
Drug: Physostigmine
Drug: Oxygen

First Posted Date: 2010-07-28

Last Posted Date: 2015-04-27

Lead Sponsor: University of Rochester

Target Recruit Count: 10

Registration Number: NCT01171118

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Open-Label Trial Comparing Oxycodone Medications

Phase 4

Terminated

Conditions: Chronic Pain

Interventions: Drug: Extended Release Oxycodone
Drug: Immediate Release Oxycodone

First Posted Date: 2010-07-14

Last Posted Date: 2015-07-17

Lead Sponsor: University of Rochester

Target Recruit Count: 18

Registration Number: NCT01162304

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Improving Psoriasis Through Health and Well-Being

Not Applicable

Completed

Conditions: Psoriasis

Interventions: Behavioral: Mindfulness-Based Stress Reduction
Behavioral: Living Well

First Posted Date: 2010-07-14

Last Posted Date: 2014-08-13

Lead Sponsor: University of Rochester

Target Recruit Count: 130

Registration Number: NCT01162252

Locations: 🇺🇸
University of Rochester; University Dermatology Associates, Rochester, New York, United States

Teen Asthma Project

Not Applicable

Completed

Conditions: Asthma

Interventions: Behavioral: Peer-assisted asthma self-management program
Behavioral: Adult-led asthma self-management program

First Posted Date: 2010-07-13

Last Posted Date: 2014-12-15

Lead Sponsor: University of Rochester

Target Recruit Count: 126

Registration Number: NCT01161225

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

The Effects of Lovaza® in Acute Myocardial Infarction

Phase 1

Terminated

Conditions: Myocardial Infarction

Interventions: Drug: Lovaza®
Drug: The placebo contained 1 gram of corn oil in each capsule.

First Posted Date: 2010-07-01

Last Posted Date: 2017-11-06

Lead Sponsor: University of Rochester

Target Recruit Count: 4

Registration Number: NCT01155336

Locations: 🇺🇸
University or Rochester, Rochester, New York, United States

Pilot Study of Fosamax in Spinal Cord Injury

Not Applicable

Terminated

Conditions: Spinal Cord Injury
Osteoporosis

Interventions: Drug: Fosamax
Drug: Placebo

First Posted Date: 2010-05-27

Last Posted Date: 2016-01-29

Lead Sponsor: University of Rochester

Target Recruit Count: 1

Registration Number: NCT01131884

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸
University of Rochester Physical Medicine and Rehabilitation, Rochester, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy